Inhibition of carcinogen-induced chromosomal aberrations by an anticarcinogenic protease inhibitor.
PDF (881K)
Journal: 1980/November - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
PUBMED: 6932036
Abstract:
It was hypothesized that chemicals- and radiation-induced carcinogenesis might require at least two specific chromosomal events that must coincide within a single target cell: (i) induction of chromosomal changes, possibly mutations, that are recessive and therefore latent in diploid somatic cells and (ii) aberrant mitotic segregation events that will convert the heterozygous cell, created by the first process, into a homozygous or hemizygous cell through chromosomal rearrangements. Hence, we tested the prediction that an inhibitor of induced carcinogenesis may inhibit one or both of these chromosomal events by studying the effects of antipain, a protease inhibitor and known inhibitor of carcinogenesis, on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced mutagenesis, chromosomal aberrations, sister chromatid exchanges, and cell killing in V79 Chinese hamster cells. We show that antipain inhibited MNNG-induced chromosomal exchanges and all other chromosomal aberrations exclusively. This results leads us to postulate that MNNG-induced DNA lesions cause chromosomal aberrations which arise through an antipain-sensitive cellular process, that some chromosomal rearrangement is a rate-limiting step in carcinogenesis, and that mutagenesis alone, if required, is not sufficient to accomplish carcinogenesis.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(6)
References
(19)
Conditions
(1)
Chemicals
(5)
Organisms
(3)
Processes
(4)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 77(6): 3544-3547
PMID: 6932036

Inhibition of carcinogen-induced chromosomal aberrations by an anticarcinogenic protease inhibitor.

Abstract

It was hypothesized that chemicals- and radiation-induced carcinogenesis might require at least two specific chromosomal events that must coincide within a single target cell: (i) induction of chromosomal changes, possibly mutations, that are recessive and therefore latent in diploid somatic cells and (ii) aberrant mitotic segregation events that will convert the heterozygous cell, created by the first process, into a homozygous or hemizygous cell through chromosomal rearrangements. Hence, we tested the prediction that an inhibitor of induced carcinogenesis may inhibit one or both of these chromosomal events by studying the effects of antipain, a protease inhibitor and known inhibitor of carcinogenesis, on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced mutagenesis, chromosomal aberrations, sister chromatid exchanges, and cell killing in V79 Chinese hamster cells. We show that antipain inhibited MNNG-induced chromosomal exchanges and all other chromosomal aberrations exclusively. This results leads us to postulate that MNNG-induced DNA lesions cause chromosomal aberrations which arise through an antipain-sensitive cellular process, that some chromosomal rearrangement is a rate-limiting step in carcinogenesis, and that mutagenesis alone, if required, is not sufficient to accomplish carcinogenesis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (881K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 3544
3544
icon of scanned page 3545
3545
icon of scanned page 3546
3546
icon of scanned page 3547
3547

Images in this article

Image
Image
on p.3545
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Schroeder TM, German J. Bloom's syndrome and Fanconi's anemia: demonstration of two distinctive patterns of chromosome disruption and rearrangement. Humangenetik. 1974;25(4):299–306. [PubMed] [Google Scholar]
  • Cohen MM, Shaham M, Dagan J, Shmueli E, Kohn G. Cytogenetic investigations in families with ataxia-telangiectasia. Cytogenet Cell Genet. 1975;15(5):338–356. [PubMed] [Google Scholar]
  • Therman E, Kuhn EM. Cytological demonstration of mitotic crossing-over in man. Cytogenet Cell Genet. 1976;17(5):254–267. [PubMed] [Google Scholar]
  • SHAW MW, COHEN MM. CHROMOSOME EXCHANGES IN HUMAN LEUKOCYTES INDUCED BY MITOMYCIN C. Genetics. 1965 Feb;51:181–190.[PMC free article] [PubMed] [Google Scholar]
  • Huttner KM, Ruddle FH. Study of mitomycin C-induced chromosomal exchange. Chromosoma. 1976 Jun 30;56(1):1–13. [PubMed] [Google Scholar]
  • Kennedy AR, Little JB. Protease inhibitors suppress radiation-induced malignant transformation in vitro. Nature. 1978 Dec 21;276(5690):825–826. [PubMed] [Google Scholar]
  • Umezawa H. Structures and activities of protease inhibitors of microbial origin. Methods Enzymol. 1976;45:678–695. [PubMed] [Google Scholar]
  • Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 1974 Sep 13;251(5471):156–158. [PubMed] [Google Scholar]
  • Myhr BC, Dipalo JA. Requirement for cell dispersion prior to selection of induced azaguanine-resistant colonies of Chinese hamster cells. Genetics. 1975 May;80(1):157–169.[PMC free article] [PubMed] [Google Scholar]
  • Savage JR. Classification and relationships of induced chromosomal structual changes. J Med Genet. 1976 Apr;13(2):103–122.[PMC free article] [PubMed] [Google Scholar]
  • Hozumi M, Ogawa M, Sugimura T, Takeuchi T, Umezawa H. Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Res. 1972 Aug;32(8):1725–1728. [PubMed] [Google Scholar]
  • Kinsella AR, Radman M. Tumor promoter induces sister chromatid exchanges: relevance to mechanisms of carcinogenesis. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6149–6153.[PMC free article] [PubMed] [Google Scholar]
  • Peto R, Roe FJ, Lee PN, Levy L, Clack J. Cancer and ageing in mice and men. Br J Cancer. 1975 Oct;32(4):411–426.[PMC free article] [PubMed] [Google Scholar]
  • GERMAN J. CYTOLOGICAL EVIDENCE FOR CROSSING-OVER IN VITRO IN HUMAN LYMPHOID CELLS. Science. 1964 Apr 17;144(3616):298–301. [PubMed] [Google Scholar]
  • Chaganti RS, Schonberg S, German J. A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4508–4512.[PMC free article] [PubMed] [Google Scholar]
  • Kuhn EM. Mitotic chiasmata and other quadriradials in mitomycin C-treated Bloom's syndrome lymphocytes. Chromosoma. 1978 Apr 25;66(3):287–297. [PubMed] [Google Scholar]
  • Holliday R. Further evidence for an inducible recombination repair system in Ustilago maydis. Mutat Res. 1975 Jul;29(1):149–153. [PubMed] [Google Scholar]
  • Fabre F, Roman H. Genetic evidence for inducibility of recombination competence in yeast. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1667–1671.[PMC free article] [PubMed] [Google Scholar]
  • Knudson AG., Jr Retinoblastoma: a prototypic hereditary neoplasm. Semin Oncol. 1978 Mar;5(1):57–60. [PubMed] [Google Scholar]
Copyright notice
Abstract
It was hypothesized that chemicals- and radiation-induced carcinogenesis might require at least two specific chromosomal events that must coincide within a single target cell: (i) induction of chromosomal changes, possibly mutations, that are recessive and therefore latent in diploid somatic cells and (ii) aberrant mitotic segregation events that will convert the heterozygous cell, created by the first process, into a homozygous or hemizygous cell through chromosomal rearrangements. Hence, we tested the prediction that an inhibitor of induced carcinogenesis may inhibit one or both of these chromosomal events by studying the effects of antipain, a protease inhibitor and known inhibitor of carcinogenesis, on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced mutagenesis, chromosomal aberrations, sister chromatid exchanges, and cell killing in V79 Chinese hamster cells. We show that antipain inhibited MNNG-induced chromosomal exchanges and all other chromosomal aberrations exclusively. This results leads us to postulate that MNNG-induced DNA lesions cause chromosomal aberrations which arise through an antipain-sensitive cellular process, that some chromosomal rearrangement is a rate-limiting step in carcinogenesis, and that mutagenesis alone, if required, is not sufficient to accomplish carcinogenesis.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.